An extensive screening revealed that, in BC cell lines, Breast tumor-related kinase (Brk) bound p27 with higher affinity than other kinases of the Src family and modulation of Brk affected p27 phosphorylation and Palbociclib sensitivity (87). Here, CDKN1B is linked to breast cancer.